Correlation Between BioNTech and Coty
Can any of the company-specific risk be diversified away by investing in both BioNTech and Coty at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Coty into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Coty Inc, you can compare the effects of market volatilities on BioNTech and Coty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Coty. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Coty.
Diversification Opportunities for BioNTech and Coty
Very weak diversification
The 3 months correlation between BioNTech and Coty is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Coty Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coty Inc and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Coty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coty Inc has no effect on the direction of BioNTech i.e., BioNTech and Coty go up and down completely randomly.
Pair Corralation between BioNTech and Coty
Given the investment horizon of 90 days BioNTech SE is expected to generate 1.4 times more return on investment than Coty. However, BioNTech is 1.4 times more volatile than Coty Inc. It trades about -0.12 of its potential returns per unit of risk. Coty Inc is currently generating about -0.18 per unit of risk. If you would invest 12,076 in BioNTech SE on September 24, 2024 and sell it today you would lose (768.00) from holding BioNTech SE or give up 6.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BioNTech SE vs. Coty Inc
Performance |
Timeline |
BioNTech SE |
Coty Inc |
BioNTech and Coty Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioNTech and Coty
The main advantage of trading using opposite BioNTech and Coty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Coty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coty will offset losses from the drop in Coty's long position.BioNTech vs. Fate Therapeutics | BioNTech vs. Sana Biotechnology | BioNTech vs. Caribou Biosciences | BioNTech vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |